524636
Phosphatase Inhibitor Cocktail II
lyophilized solid, for the inhibition of acid and alkaline phosphatases and protein tyrosine phosphatases, This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
别名:
Inhibitor Cocktail
登录查看公司和协议定价
所有图片(1)
About This Item
分類程式碼代碼:
12352200
NACRES:
NA.54
推荐产品
产品名称
Phosphatase Inhibitor Cocktail Set II, Lyophilized, The Phosphatase Inhibitor Cocktail Set II, Lyophilized controls the activity of Phosphatase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.
品質等級
形狀
solid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
desiccated (hygroscopic)
protect from light
運輸包裝
ambient
儲存溫度
2-8°C
一般說明
A cocktail of five phosphatase inhibitors for the inhibition of acid and alkaline phosphatases as well as protein tyrosine phosphatases (PTPs). Suitable for use with cell lysates and tissue extracts, including samples containing detergents. Provided as a set of five vials. Each vial, when reconstituted with 1 ml H2O, contains Imidazole (200 mM), Sodium Fluoride (100 mM), Sodium Molybdate (115 mM), activated Sodium Orthovanadate (100 mM), and Sodium Tartrate Dihydrate (400 mM). Reconstitute each vial with 1 ml H2O.
包裝
Packaged under inert gas
警告
Toxicity: Toxic (F)
重構
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Dilute 1:100 just prior to use.
Reconstitute each vial with 1 ml H₂O.
其他說明
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Danger
危險聲明
危險分類
Acute Tox. 4 Oral - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類（WGK）
WGK 3
其他客户在看
Delphine Séhédic et al.
Frontiers in bioengineering and biotechnology, 8, 602998-602998 (2021-03-16)
Inhibition of the PI3K/Akt/mTOR signaling pathway represents a potential issue for the treatment of cancer, including glioblastoma. As such, rapamycin that inhibits the mechanistic target of rapamycin (mTOR), the downstream effector of this signaling pathway, is of great interest. However
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门